STRAUMANN HOLDING AG

Swiss stocks closed flat on Monday as inflation fears, interest‑rate concerns, and oil‑price spikes kept sentiment cautious. Sonova, Lonza, and Sika led modest gains, while Logitech and Straumann slipped slightly. The SLI finished near 2,249 points,…

Explore why Straumann Holding AG is a “hidden champion” in dental implants—high margins, AI‑driven tools, and attractive valuation discounts could drive upside, but supply chain, currency, and regulatory risks remain.

Swiss market indices stay flat as bond yields rise—insurers and pharma lead the way, while tech lags. Discover how defensive stocks thrive amid shifting macro‑winds and regulatory changes.

Straumann Holding AG’s shares rise 1.5%, showing strong resilience in the Swiss market, driven by innovation, diversification, and growing implant demand.

Swiss equity market stays resilient: Novartis, Straumann, Holcim and Sandoz drive gains amid geopolitical tensions, rising oil, and Fed hikes.

Explore Straumann Holding’s resilient strategy amid Swiss market volatility, digital dentistry growth, and regenerative medicine opportunities—why the company remains a strong investment choice.

Swiss market dips Monday as Middle East tensions and muted U.S. rate expectations weigh on SMI, with Nestlé, Richemont, and Straumann falling in a cautious European trend.

Swiss markets dip as volatility spikes and earnings loom, with key companies like Givaudan and Lindt slipping while Alcon climbs—US CPI data set to sway investor sentiment.

Swiss equities fell this week, but a deep dive shows sector shifts, earnings trends, and regulatory pressures that could unlock hidden upside for investors.

Explore Straumann’s 2026 earnings: rising sales, strong margins, and AI‑driven dental tech—while navigating MDR, supply‑chain risks, and low‑cost competition.